Cyanotech Co. (OTCMKTS:CYAN) Short Interest Up 2,477.2% in July

Cyanotech Co. (OTCMKTS:CYAN) was the target of a large increase in short interest in July. As of July 15th, there was short interest totaling 2,938 shares, an increase of 2,477.2% from the June 30th total of 114 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average trading volume of 3,344 shares, the short-interest ratio is presently 0.9 days.

Cyanotech Stock Performance

Cyanotech stock opened at $0.53 on Friday. The company has a market cap of $3.91 million, a PE ratio of -2.12 and a beta of 0.12. The company has a fifty day moving average price of $0.48 and a two-hundred day moving average price of $0.42. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 0.42. Cyanotech has a 12 month low of $0.21 and a 12 month high of $0.57.

Cyanotech (OTCMKTS:CYAN) last released its earnings results on Monday, June 29th. The biotechnology company reported $0.00 earnings per share for the quarter. Cyanotech had a negative net margin of 4.82% and a negative return on equity of 16.24%.

Cyanotech Company Profile

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.